Table 2 Baseline characteristics of patients
Good neurological outcome (n = 19) | Poor neurological outcome (n = 39) | p Value | |
|---|---|---|---|
Age, yr, median (IQR) | 50.0 (32.0–54.5) | 54.0 (45.0–61.0) | 0.136 |
Gender, male, n (%) | 15 (78.9) | 29 (74.4) | 0.955 |
Body mass index, kg/m2 | 23.1 (21.6–25.8) | 25.5 (22.4–28.3) | 0.064 |
Medical history, n (%) | |||
Diabetes mellitus | 3 (15.8) | 15 (38.5) | 0.147 |
Hypertension | 6 (31.6) | 18 (46.2) | 0.439 |
Malignancy | 1 (5.3) | 5 (12.8) | 0.669 |
Dyslipidemia | 1 (5.3) | 6 (15.4) | 0.496 |
Current smoker | 6 (31.6) | 14 (35.9) | 0.976 |
Previous myocardial infarction | 0 (0) | 6 (15.4) | 0.178 |
Targeted temperature management, n (%) | 0.928 | ||
Arctic Sun® | 11 (57.9) | 24 (61.5) | |
Cooling pad | 2 (10.5) | 3 (7.7) | |
Initial Glasgow Coma Scale score, median (IQR) | 3.0 (3.0–3.0) | 3.0 (3.0–3.0) | 0.208 |
Laboratory data on admission | |||
Initial lactate, mmol/L | 12.4 (10.1–15.1) | 8.8 (7.3–13.3) | 0.071 |
Hemoglobin before ECMO, g/dl | 15.0 (12.6–15.5) | 13.2 (11.3–14.8) | 0.099 |
Hemoglobin after ECMO, g/dl | 11.1 (9.8–12.4) | 12.1 (9.7–13.1) | 0.449 |
Total bilirubin, mg/dl | 0.7 (0.3–0.9) | 0.8 (0.5–1.1) | 0.210 |
Blood urea nitrogen, mg/dl | 15.0 (10.6–18.0) | 15.5 (13.0–23.5) | 0.223 |
Creatinine, mg/dl | 1.1 (1.0–1.3) | 1.2 (1.0–1.7) | 0.292 |
Bicarbonate, IU/L | 11.7 (10.3–17.9) | 17.7 (13.2–20.9) | 0.121 |